Medicine and Dentistry
Adenocarcinoma
20%
Adjuvant Chemotherapy
9%
Adjuvant Therapy
12%
Biological Marker
9%
Cancer
16%
Carcinomatous Peritonitis
32%
Cholecystectomy
10%
Colorectal Liver Metastasis
27%
Cytoreductive Surgery
100%
Diaphragm
8%
Diseases
10%
Distal Pancreatectomy
9%
Gallbladder Cancer
29%
Health Care Cost
9%
Hepatectomy
10%
Hepatobiliary Cancer
9%
Hepatocellular Carcinoma
9%
Hyperthermic Intraperitoneal Chemotherapy
99%
Infusion Fluid
7%
Intensive Care Unit
8%
Learning Curve
9%
Liver Tumor
9%
Lower Anterior Resection
9%
Lymph Node
9%
Lymphocyte
9%
Midgut volvulus
9%
Multivariate Analysis
11%
Neoadjuvant Chemotherapy
11%
Neoplasm
41%
Opiate
18%
Overall Survival
28%
Pancreas Adenocarcinoma
9%
Pancreas Cancer
9%
Pancreaticoduodenectomy
18%
Patient Selection
18%
Peritoneum Cancer
24%
Peritoneum Metastasis
27%
Primary Tumor
10%
Proton-Pump Inhibitor
9%
Recurrent Disease
18%
Retroperitoneal Lymph Node Dissection
9%
Sigmoid
9%
Splenic Flexure
9%
Squamous Cell Carcinoma
9%
Stomach Paresis
9%
Surgery
52%
Surgical Oncology
9%
Transversus Abdominis Plane Block
18%
Treatment Effect
9%
Ultrasonography
9%
Keyphrases
Ablating
18%
Adenocarcinoma
11%
Adenocarcinoma Subtype
9%
Adjuvant Therapy
13%
Appendiceal
10%
Area Deprivation
9%
Area Deprivation Index
9%
Colorectal Liver Metastases
27%
Cytoreductive Surgery
89%
Duodenum
9%
Embolize
18%
Gallbladder
10%
Gallbladder Cancer
36%
High-volume Center
12%
Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
100%
Learning Curve
9%
Liver Ultrasound
9%
Low-grade Appendiceal mucinous Neoplasm
20%
Minimally Invasive
12%
Molecular Biomarkers
9%
Multivariate Analysis
11%
Neoadjuvant Chemotherapy
10%
Normal Anatomy
9%
Oncological Outcomes
12%
Opiate Consumption
10%
Opiate Use
18%
Overall Survival
21%
Pancreatic Cancer
9%
Pancreatic Resection
14%
Pancreaticoduodenectomy
18%
Partial Response
9%
Pathologic
12%
Patient Selection
21%
Peritoneal Cancer Index
23%
Peritoneal Carcinomatosis
31%
Peritoneal Metastasis
27%
Postoperative Day
9%
Postoperative Outcomes
18%
Primary Tumor
10%
Resection
16%
Response to Neoadjuvant Chemotherapy
9%
Single Institution
11%
Splenic Flexure Mobilization
9%
Surgical Management
10%
Surgical Oncology
9%
Total Lymph Node Count
9%
Transversus Abdominis Plane Block
18%
Treatment Effect
9%
Tumor
19%
Whirlpool
9%